Star Combo Pharma (S66) Stock Overview
Manufactures and distributes health food products and nutritional supplements in Australia and China. More details
| Snowflake Score | |
|---|---|
| Valuation | 4/6 |
| Future Growth | 0/6 |
| Past Performance | 5/6 |
| Financial Health | 6/6 |
| Dividends | 2/6 |
S66 Community Fair Values
See what others think this stock is worth. Follow their fair value or set your own to get alerts.
Star Combo Pharma Limited Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | AU$0.20 |
| 52 Week High | AU$0.28 |
| 52 Week Low | AU$0.13 |
| Beta | 0.36 |
| 1 Month Change | -13.33% |
| 3 Month Change | -4.88% |
| 1 Year Change | 18.18% |
| 3 Year Change | 69.57% |
| 5 Year Change | -23.53% |
| Change since IPO | -75.32% |
Recent News & Updates
Benign Growth For Star Combo Pharma Limited (ASX:S66) Underpins Stock's 26% Plummet
Star Combo Pharma Limited ( ASX:S66 ) shareholders won't be pleased to see that the share price has had a very rough...Insufficient Growth At Star Combo Pharma Limited (ASX:S66) Hampers Share Price
Star Combo Pharma Limited's ( ASX:S66 ) price-to-earnings (or "P/E") ratio of 8.5x might make it look like a strong buy...Is Now The Time To Put Star Combo Pharma (ASX:S66) On Your Watchlist?
For beginners, it can seem like a good idea (and an exciting prospect) to buy a company that tells a good story to...Star Combo Pharma Limited's (ASX:S66) Share Price Boosted 31% But Its Business Prospects Need A Lift Too
Despite an already strong run, Star Combo Pharma Limited ( ASX:S66 ) shares have been powering on, with a gain of 31...Recent updates
Shareholder Returns
| S66 | AU Personal Products | AU Market | |
|---|---|---|---|
| 7D | -4.9% | -6.2% | 0.08% |
| 1Y | 18.2% | -33.4% | 3.1% |
Return vs Industry: S66 exceeded the Australian Personal Products industry which returned -34.7% over the past year.
Return vs Market: S66 exceeded the Australian Market which returned 2.9% over the past year.
Price Volatility
| S66 volatility | |
|---|---|
| S66 Average Weekly Movement | 12.2% |
| Personal Products Industry Average Movement | 12.2% |
| Market Average Movement | 10.5% |
| 10% most volatile stocks in AU Market | 17.5% |
| 10% least volatile stocks in AU Market | 4.3% |
Stable Share Price: S66 has not had significant price volatility in the past 3 months compared to the Australian market.
Volatility Over Time: S66's weekly volatility (12%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2004 | n/a | Su Zhang | www.starcombo.com.au |
Star Combo Pharma Limited manufactures and distributes health food products and nutritional supplements in Australia and China. It operates in two segments, OEM and Retail. The company develops, manufactures, markets, and sells natural health supplements and skin care products.
Star Combo Pharma Limited Fundamentals Summary
| S66 fundamental statistics | |
|---|---|
| Market cap | AU$26.34m |
| Earnings (TTM) | AU$4.12m |
| Revenue (TTM) | AU$23.99m |
Is S66 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| S66 income statement (TTM) | |
|---|---|
| Revenue | AU$23.99m |
| Cost of Revenue | AU$18.02m |
| Gross Profit | AU$5.98m |
| Other Expenses | AU$1.86m |
| Earnings | AU$4.12m |
Last Reported Earnings
Dec 31, 2025
Next Earnings Date
n/a
| Earnings per share (EPS) | 0.03 |
| Gross Margin | 24.91% |
| Net Profit Margin | 17.16% |
| Debt/Equity Ratio | 0.1% |
How did S66 perform over the long term?
See historical performance and comparisonDividends
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2026/05/22 06:40 |
| End of Day Share Price | 2026/05/22 00:00 |
| Earnings | 2025/12/31 |
| Annual Earnings | 2025/06/30 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
Star Combo Pharma Limited is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.